Cite
Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells.
MLA
Zhou, Jianwen, et al. “Combined Using of Paclitaxel and Salinomycin Active Targeting Nanostructured Lipid Carriers against Non-Small Cell Lung Cancer and Cancer Stem Cells.” Drug Delivery, vol. 26, no. 1, Dec. 2019, pp. 281–89. EBSCOhost, https://doi.org/10.1080/10717544.2019.1580799.
APA
Zhou, J., Sun, M., Jin, S., Fan, L., Zhu, W., Sui, X., Cao, L., Yang, C., & Han, C. (2019). Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells. Drug Delivery, 26(1), 281–289. https://doi.org/10.1080/10717544.2019.1580799
Chicago
Zhou, Jianwen, Mingshuang Sun, Shanshan Jin, Li Fan, Wenquan Zhu, Xiaoyu Sui, Lixin Cao, Chunrong Yang, and Cuiyan Han. 2019. “Combined Using of Paclitaxel and Salinomycin Active Targeting Nanostructured Lipid Carriers against Non-Small Cell Lung Cancer and Cancer Stem Cells.” Drug Delivery 26 (1): 281–89. doi:10.1080/10717544.2019.1580799.